Articles for Mediclinic International (LSE: MDC)
Is the RBS share price or this falling FTSE 250 knife the brighter bargain today?
Rupert Hargreaves | Saturday, 1st December, 2018
Royal Bank of Scotland plc's (LON: RBS) share price looks attractive, but this FTSE 250 (INDEXFTSE: UKX) turnaround could be a better buy. More »
Why I think it’s time to buy this FTSE 100 stock, down 25% in two months
Rupert Hargreaves | Wednesday, 17th October, 2018
Rupert Hargreaves discusses the valuation and prospects of a fallen FTSE 100 (INDEXFTSE: UKX) flyer and a savaged mid-cap with a trading update out... More »
This FTSE 100 growth stock looks a far safer bet than bitcoin
Alan Oscroft | Wednesday, 30th May, 2018
If you're thinking of investing in bitcoin, here's a FTSE 100 (INDEXFTSE: UKX) growth candidate that could be a lot less risky. More »
Is the Mediclinic International share price a FTSE 100 bargain or a value trap?
Rupert Hargreaves | Thursday, 24th May, 2018
Rupert Hargreaves considers whether FTSE 100 (INDEXFTSE: UKX) hospital giant Mediclinic International plc (LON: MDC) deserves a place in your portfolio. More »
Mediclinic International: a top FTSE 100 healthcare stock?
Edward Sheldon, CFA | Wednesday, 18th April, 2018
Mediclinic International plc (LON: MDC) shares are up 5% today. Are they worth a closer look? More »
Is Burberry Group plc a top Footsie turnaround buy today?
G A Chester | Wednesday, 17th January, 2018
G A Chester evaluates Burberry Group plc (LON:BRBY) and another FTSE 100 (INDEXFTSE: UKX) turnaround prospect. More »
Why I’d sell this turnaround stock to buy a ‘secret’ FTSE 100 growth stock
Alan Oscroft | Tuesday, 28th November, 2017
From small-caps to the FTSE 100 (INDEXFTSE: UKX), there are growth opportunities to be found everywhere. More »
Why I’d buy this dividend stock over Barclays plc
Rupert Hargreaves | Thursday, 16th November, 2017
Barclays plc's (LON: BARC) dividend potential is limited. This stock is a better buy. More »
Why I’d sell this FTSE 100 growth stock for its rival’s big dividend
Ian Pierce | Tuesday, 17th October, 2017
This growth stock's lofty valuation has me looking at its FTSE 100 (INDEXFTSE: UKX) peer's 3.9% yield and more reasonable valuation. More »
2 FTSE 100 growth stocks you can retire on
Rupert Hargreaves | Wednesday, 5th July, 2017
These two defensive growth champions could be great investments for retirement. More »
2 super growth stocks you need to check out today
Royston Wild | Wednesday, 24th May, 2017
Royston Wild considers the growth outlook of two mid-week newsmakers. More »
Is Mediclinic International plc a screaming buy as shares surge 20% higher?
Ian Pierce | Thursday, 27th April, 2017
Regulatory rollbacks send shares of Mediclinic International plc (LON: MDC) soaring 20%. Time to buy? More »
2 growth stars set to beat the FTSE 100
Peter Stephens | Thursday, 13th April, 2017
These two companies appear to have relatively low valuations given their growth prospects. More »
Could South Africa’s junk status trash these 3 stocks?
Harvey Jones | Tuesday, 4th April, 2017
Troubles in South Africa have hit home for these three UK-listed stocks, says Harvey Jones. More »
4 stocks I’d buy near 52-week lows
Harvey Jones | Wednesday, 1st March, 2017
The only way is up for these for bottom scrapers, says Harvey Jones. More »
Over 15% upside by 2019 despite profit warning sending this stock 7% lower
Peter Stephens | Tuesday, 21st February, 2017
This stock could be worth buying even after a profit warning. More »
Beat the January sales with these blue-chip bargains
Bilaal Mohamed | Wednesday, 4th January, 2017
Bilaal Mohamed spots two blue-chip bargains that could post healthy gains in 2017. More »
These FTSE 100 stocks sank in Q4. Can they rebound in 2017?
Royston Wild | Tuesday, 3rd January, 2017
Royston Wild considers the share price outlook of two FTSE 100 (INDEXFTSE: UKX) crashers. More »
Which of these Footsie healthcare stars should you buy after today’s news?
Royston Wild | Thursday, 10th November, 2016
Royston Wild discusses the investment prospects of two Footsie medical giants. More »
Are these FTSE 100 fallers poised to bounce back?
Royston Wild | Wednesday, 19th October, 2016
Royston Wild considers the rebound potential of two FTSE 100 (INDEXFTSE: UKX) giants. More »
